Member Info for HedgeHogarth

Breaking News - JHFH thinking of shorting Hemo ;-)

Bring on the selling - happy for this to take a small breather to allow a few top-ups at this level before we go again :-)

How is that NANO trade going Pumpky - have you run for the hills yet?

I'm surprised the trolls has not tried to discredit you yet JHFH.
The smart ones on here though will know that you are simply re-sharing what is in the RNS, from Vlad's interviews and the genuine reasons that have seen you become some a big shareholder.
We've probably all become bigger shareholders than we would have planned - but the low McAP has created that opportunity - which has been irresistible and a chance to average down.
GLA - looking forward to the next RNS with excitement and interested to see how the market plays out in anticipation of that

With a few tweaks to my SIPP i managed to free up some cash and put (for me) a large buy order in case the SP fell back today - with mixed feelings, it did not trigger

Let's keep this board informative and healthy debate like it has been for most of week.

Don't play with the trolls or bicker.

Bump...
Almost 40 people were kind enough to like this yesterday so worth reposting

>60m shared traded today - best volume in 15mths
A solid 25-30% gain today - building on the +50% gain over the previous 5 days of trading
Ladies and gentlemen - we have MOMENTUM
With a news rich period ahead of us I think these gains will soon be forgotten - IND and transition to clinical trials will prove pivotal
We also found out today that CBR is every bit as promising as we had already learnt from previous company updates. CDX remains the 2nd priority - and continues to progress is spite of CAR-T being the No 1 priority
Rewards can be HUGE in Biotech and the whole sector seems set for a strong 2023

Hemo hold all the aces - most of what they are developing is already protected and proprietary. Partnerships have ALWAYS been the long term plan for Hemo - and we can expect updates in that space this year IMO on any of the 3 product candidates
We also learnt today that Hemogenyx are very much engaged with the US Government - we know they have an interest in pursuing Biodefense which Biden has set aside a huge budget

Apologies if this sounds like i am Ramping - maybe it is ramping but I can assure you that I'm simply well researched and highly invested. . Apart from my SIPP and ISA being significantly overweight in Hemo, I struggle to see the downside. My biggest short term concern would be that CAR-T does not make it to clinical trials - but with 2 out of 3 runs now successful and great engagement already with the FDA - the risk is low IMO.

Hemo are well funded for the next 12-18mth - based on what they have planned.

This company is valued at just £22.5m with up to £5m in the bank - the McAP previously hit the dizzy heights of £60-£70m when it had less than £1m cash, significantly less progress on CAR-T and no value attached to CBR - and were still in their old premises.

I will be very surprised if we do not see a McAP above of £50m and beyond before Easter - hopefully sooner as news can arrive anytime. This would equate to an share price between of 5p and 6p.

Good luck to everyone - suggest you join me in raising a glass tonight to celebrate almost +100% rise in the last few weeks + to another 100% rise in the coming days/weeks/months.

Suggest you all read the last 12mths of updates from the company VS waste a minute of your life reading what the trolls post on here. We all know why they are here, simple trouble makers trying to create doubt for their own financial gain.

They only have days or weeks left before Hemo announce the next outcome of Hemo CAR-T. So they will be trying very hard to hold this back.

Mind you, every cloud has a silver lining and if the MMs take this lower for their own reasons or are due to selling / shorting it creates some wonderful buying opportunities. Seen this all before...

>60m shared traded today - best volume in 15mths
A solid 25-30% gain today - building on the +50% gain over the previous 5 days of trading
Ladies and gentlemen - we have MOMENTUM
With a news rich period ahead of us I think these gains will soon be forgotten - IND and transition to clinical trials will prove pivotal
We also found out today that CBR is every bit as promising as we had already learnt from previous company updates. CDX remains the 2nd priority - and continues to progress is spite of CAR-T being the No 1 priority
Rewards can be HUGE in Biotech and the whole sector seems set for a strong 2023

Hemo hold all the aces - most of what they are developing is already protected and proprietary. Partnerships have ALWAYS been the long term plan for Hemo - and we can expect updates in that space this year IMO on any of the 3 product candidates
We also learnt today that Hemogenyx are very much engaged with the US Government - we know they have an interest in pursuing Biodefense which Biden has set aside a huge budget for.

Apologies if this sounds like i am Ramping - maybe it is ramping but I can assure you that I'm simply well researched and highly invested. . Apart from my SIPP and ISA being significantly overweight in Hemo, I struggle to see the downside. My biggest short term concern would be that CAR-T does not make it to clinical trials - but with 2 out of 3 runs now successful and great engagement already with the FDA - the risk is low IMO.

Hemo are well funded for the next 12-18mth - based on what they have planned.

This company is valued at just £22.5m with up to £5m in the bank - the McAP previously hit the dizzy heights of £60-£70m when it had less than £1m cash, significantly less progress on CAR-T and no value attached to CBR - and were still in their old premises.

I will be very surprised if we do not see a McAP above of £50m and beyond before Easter - hopefully sooner as news can arrive anytime. This would equate to an share price between of 5p and 6p.

Good luck to everyone - suggest you join me in raising a glass tonight to celebrate almost +100% rise in the last few weeks + to another 100% rise in the coming days/weeks/months.

The 1.9m trade was reported late - so not sure is that is a buy or sell as spread was probably not 2.45 / 2.50 at the time of the transaction

Shorting works when doubt can be created as to the value of the company. This usually follows a period SP growth - the difference today is the growth still falls well short of most people's conservative valuations

Hemo remains undervalued given their progress towards the clinic with CAR-T (weeks away now) and today's great update on CBR. (And not forgetting CDX which is also in the Hemo toolkit)

OMG.....did not imagine the RNS to come quite so soon or be quite that good.

I imagine Hemo will have a choice of partnership models to exploit this wonderful opportunity for humanity.

With antibiotics starting to fail, I wonder if this could find infections too?

I very much hope this settles down now - I want the SP to grow consistently all year. I don't want to see this spike - which is a risk if too many short term traders are attracted. They can still get in for sub 2p and would almost certainly cash in between 2.5 and 3.5p. The only hope is that tangible "value adding" news is announced by the company to back up any spike.

Personally, I think we should stay a little quiet and let sleeping dogs lie. The next RNS should attract the right investors

It says it's a rare business related tweet.....

You have won Hemogenyx....??

Would love for you to be right on having an update on one of the other candidates.

It would not surprise me, although I am not as optimistic as you on the timing.

Hemo are a matter of weeks away from clinical trials, testing carT on humans. This is huge, this is what Vlad has worked all his life for. So I would forgive Hemo if they all eyes on that prize, at the expense of quicker progress on CBR.

The pivotal difference is one year of significant progress, no curve balls.

What has not changed is Hemo was undervalued when it hit 2p on the way down and is still undervalued when hitting 2p on the way back up.

I agree that CarT results are critical, but not to justify 2-3p, they are should had 2 to 3 times more than that

Lots of shares sold at 1.9 and even higher today - This means someone or some people are happy to buy for higher than that.....

Quite a change vs 2 weeks ago when you could buy shares for 1.25. This signals a big pivot in momentum and prospects for this share

Must be an exciting and pivotal time for Hemo - Tillywhizz visits are up about +1000% and very welcome #goodtimes

c17m shares traded today...would not mind betting a couple of biggies not yet reported